Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice

Journal of Endocrinology

Volumn 158, Issue 1, 1998, Pages 69-75

  Sternesjo J ^a   Sandler, S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DNA CONTENT; FEMALE; GLUCOSE METABOLISM; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; CULTURE TECHNIQUES; DEPRESSION, CHEMICAL; DNA; FEMALE; GLUCOSE; INSULIN; INTERLEUKIN-12; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MICE, INBRED STRAINS; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031828921     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1580069     Document Type: Article

References (35)

1. Andersson A & Sandler S 1983 Viability tests of cryopreserved endocrine pancreatic cells. Cryobiology 20 161-168.
2. Armant M, Armitage R, Boiani N, Delespesse G & Sarfati M 1996 Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin-2-induced interleukin-12 and interferon-gamma production. European Journal of Immunology 26 1430-1434.
3. DeBlaker HD, Yamauchi A, Yu CR, Horvath AJ & Bloom ET 1995 IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cellular Immunology 165 33-43.
4. Dunger A, Cunningham JM, Delaney CA, Lowe JE, Green MH, Bone AJ & Green IC 1996 Tumour necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned rat islets. Extent of nitric oxide involvement. Diabetes 45 183-189.
5. Eisenbarth GS 1986 Type I diabetes mellitus. A chronic autoimmune disease. New England Journal of Medicine 314 1360-1368.
6. Eizirik DL, Sandler S, Welsh N, Cetkovic CM, Nieman A, Geller DA, Pipeleers DG, Bendtzen K & Hellerstrom C 1994 Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. Journal of Clinical Investigation 93 1968-1974.
7. Gepts W 1965 Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14 619-633.
8. 15N]nitrate in biological fluids. Analytical Biochemistry 126 131-138.
9. Heding LG 1972 Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8 260-266.
10. Hinegardner RT 1971 An improved fluorometric assay for DNA. Analytical Biochemistry 39 197-201.
11. Keen H, Field JB & Pastan IH 1963 A simple method for in vivo metabolic studies using small volumes of tissue and medium. Metabolism 12 143-147.
12. Kissane JM & Robins E 1958 The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. Journal of Biological Chemistry 233 184-188.
13. Krebs HA & Henseleit K 1932 Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seylers Zeitung für Physiologische Chemie 210 33-66.
14. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K & Tochino Y 1980 Breeding of a non obese, diabetic strain of mice. Experimental Animals 29 1-13.
15. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M & Nielsen JH 1986 Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29 63-67.
16. Nagata M, Yokono K, Hayakawa M, Kawase Y, Hatamori N, Ogawa W, Yonezawa K, Shii K & Baba S 1989 Destruction of pancreatic islet cells by cytotoxic T lymphocytes in non obese diabetic mice. Journal of Immunology 143 1155-1162.
17. Nakhooda AF, Like AA, Chappel CI, Wei CN & Marliss EB 1978 The spontaneously diabetic Wistar rat (the 'BB' rat). Studies prior to and during development of the overt syndrome. Diabetologia 14 199-207.
18. O'Hara RJ, Henderson SL & Nagelin A 1996 Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Annals of the New York Academy of Sciences 795 241-249.
19. Pukel C, Baquerizo H & Rabinovitch A 1987 Interleukin 2 activates BB/W diabetic rat lymphoid cells cytotoxic to islet cells. Diabetes 36 1217-1222.
20. Rabinovitch A 1994 Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43 613-621.
21. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Schulz R, Lakey JR, Warnock GL & Rajotte RV 1994 Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. Journal of Clinical Endocrinology and Metabolism 79 1058-1062.
22. Rabinovitch A, Suarez PW & Sorensen O 1996 Interleukin-12 mRNA expression in islets correlates with beta-cell destruction in NOD mice. Journal of Autoimmunity 9 645-651.
23. Rothe H, Burkart V, Faust A & Kolb H 1996 Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 39 119-122.
24. 2. Diabetologia 40 641-646.
25. Sandler S & Sternesjö J 1995 Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1. Cytokine 7 296-300.
26. Sandler S, Andersson A & Hellerström C 1987 Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121 1424-1431.
27. Sandler S, Bendtzen K, Eizirik DL & Welsh M 1990 Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinology 126 1288-1294.
28. Sternesjö J, Bendtzen K & Sandler S 1995 Effects of prolonged exposure in vitro to interferon-gamma and tumour necrosis factor-alpha on nitric oxide and insulin production of rat pancreatic islets. Autoimmunity 20 185-190.
29. Strandell E, Eizirik DL & Sandler S 1990 Reversal of beta-cell suppression in vitro in pancreatic islets isolated from non obese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. Journal of Clinical Investigation 85 1944-1950.
30. Szelachowska M, Kretowski A & Kinalska I 1997 Increased in vitro interleukin-12 production by peripheral blood in high-risk IDDM first degree relatives. Hormone and Metabolic Research 29 168-171.
31. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK & Adorini L 1995 Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. Journal of Experimental Medicine 181 817-821.
32. Trembleau S, Penna G, Gregori L & Adorini L 1996 Favoring the development of the Th2 cells by IL-12 antagonist administration prevents but does not treat IDDM. Autoimmunity 24 A118.
33. Trinchieri G 1995 Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annual Review of Immunology 13 251-276.
34. Welsh N, Eizirik DL, Bendtzen K & Sandler S 1991 Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129 3167-3173.
35. Wood PJ, Lehr J, Rabinovich A & Baquerizo H 1988 Functional characterization of cells isolated from the pancreas of non-obese diabetic mice. Transplantation Proceedings 20 324-325.